Episode 115 | Ketones and Lupus

Episode 115 | Ketones and Lupus

Treating lupus by simply suppressing the immune system can sometimes feel like fighting a complex house fire with a single tool. In this episode of The Health Pulse, we explore a newer and fascinating concept known as immunometabolism—the science of how immune cells generate energy and how those metabolic pathways may influence inflammation in systemic lupus erythematosus (SLE). We begin with the basics of lupus and why its unpredictable pattern of flare-ups and remissions makes dietary anecdotes difficult to interpret. Then we dive into the cellular level, examining how activated T cells and B cells shift toward glycolysis, consuming glucose rapidly and creating a metabolic environment that promotes oxidative stress and chronic inflammation. From there, we explore the ketogenic diet and nutritional ketosis. By restricting carbohydrates and lowering insulin, the body begins producing ketone bodies like beta-hydroxybutyrate (BHB). But BHB may be more than an alternative fuel source. Research suggests it may also function as a signaling molecule capable of influencing the NLRP3 inflammasome, a key component of the inflammatory response involved in cytokine production. We also emphasize the importance of caution. Findings from animal studies do not automatically translate into clinical benefit in humans, and lupus is an extremely heterogeneous disease. Nutritional therapies should never replace rheumatology care, and special attention is required for patients with lupus nephritis, medication adjustments, and fluid and electrolyte balance. Finally, we discuss a practical laboratory monitoring framework, including CBC, CMP, complement C3 and C4, anti-dsDNA antibodies, ESR, CRP, fasting insulin, fasting glucose, kidney function markers, ApoB, vitamin D, B12, magnesium, and iron studies. These biomarkers can provide valuable insight into both disease activity and metabolic health. Whether you're living with lupus, interested in autoimmune disease, or curious about the emerging science of immunometabolism, this episode offers an evidence-based look at one of the most promising and controversial areas in metabolic medicine. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile [https://quicklabmobile.com] 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

Episode 114 | Alzheimer’s As A Brain Energy Crisis

For decades, Alzheimer’s disease has been viewed primarily through the lens of amyloid plaques and tau tangles. But what if those hallmark features are only part of the story? In this episode of The Health Pulse, we explore a growing body of research suggesting that Alzheimer’s may also be a metabolic disease—a slow-developing energy crisis in the brain that begins years before memory loss becomes apparent. We start by examining the brain’s enormous energy demands and the surprising findings from FDG-PET imaging studies, which show reduced glucose metabolism in critical memory centers years—even decades—before an Alzheimer’s diagnosis. These findings have led researchers to investigate whether impaired energy production may play a central role in disease progression. From there, we dive into the concept of brain insulin resistance, often referred to as “Type 3 Diabetes.” Insulin in the brain does far more than regulate blood sugar—it influences learning, memory formation, synaptic plasticity, and inflammation control. When neurons become resistant to insulin, they may be surrounded by glucose yet unable to efficiently use it, setting the stage for mitochondrial dysfunction, oxidative stress, chronic inflammation, and the accumulation of abnormal proteins. We also explore one of the most intriguing areas of metabolic neuroscience: ketone metabolism. Because ketones can provide energy through pathways that are less dependent on insulin signaling, researchers are studying ketogenic diets, fasting strategies, and medium-chain triglycerides (MCTs) as potential tools to support brain energy metabolism in individuals with mild cognitive impairment or early Alzheimer’s disease. Finally, we focus on practical prevention and monitoring strategies. We discuss key biomarkers that may help assess long-term brain and metabolic health, including fasting insulin, HbA1c, glycemic variability, ApoB, inflammatory markers like hs-CRP, and nutrient markers such as vitamin B12 and vitamin D. While Alzheimer’s remains a complex disease with multiple contributing factors, the metabolic perspective offers a powerful new framework for understanding risk, prevention, and future therapeutic possibilities. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile [https://quicklabmobile.com] 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

Episode 113 | Personal Fat Threshold

Why do some people develop type 2 diabetes despite being lean, while others carry excess weight and maintain relatively normal blood sugar? In this episode of The Health Pulse, we explore the Low Personal Fat Threshold Theory, a compelling framework that challenges the conventional belief that obesity alone drives metabolic disease. Using a simple but powerful analogy, we explain why judging metabolic health by appearance is like judging a house by its paint job while ignoring the foundation. The real issue isn't how much fat you carry—it's where your body stores it and whether you've exceeded your personal capacity for safe fat storage. We break down the role of subcutaneous fat, the body's primary "safe storage" system for excess energy. Once that capacity is exceeded, fat begins to accumulate in places it doesn't belong—particularly the liver, pancreas, and skeletal muscle. This process, known as ectopic fat deposition, triggers a cascade of metabolic dysfunction. You'll learn how liver fat generates harmful lipid byproducts such as diacylglycerols (DAGs) and ceramides, disrupting insulin signaling and contributing to insulin resistance. We also explore how fat accumulation in the pancreas can promote lipotoxicity, beta-cell stress, and declining insulin production, helping explain the progression toward type 2 diabetes. The conversation also examines the role of diet quality, including how refined carbohydrates and excess fructose can accelerate de novo lipogenesis, increasing organ fat accumulation long before significant weight gain appears on the scale. Most importantly, we discuss why type 2 diabetes remission is often possible. The goal isn't simply losing weight—it's reducing liver and pancreatic fat, restoring normal metabolic function. This helps explain why relatively modest weight loss can sometimes produce dramatic improvements in blood sugar control. Finally, we review the early-warning biomarkers that may reveal metabolic dysfunction years before glucose or HbA1c become abnormal, including fasting insulin, triglycerides, HDL cholesterol, ApoB, ALT, and AST. If you've ever wondered why body weight alone fails to predict metabolic health, this episode offers a new perspective that may change how you think about diabetes prevention and reversal. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile [https://quicklabmobile.com] 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

Episode 112 | A Metabolic Perspective on ALS

What if ALS isn't just a disease of dying motor neurons—but also a disease of impaired cellular energy? In this episode of The Health Pulse, we explore a fascinating metabolic perspective on amyotrophic lateral sclerosis (ALS) and why researchers are increasingly investigating ketogenic metabolic therapy as a potential supportive strategy. We begin by examining the enormous energy demands of motor neurons. These specialized cells require a constant supply of ATP to maintain electrical signaling and communication throughout the body. When mitochondrial function declines, motor neurons may become especially vulnerable, setting the stage for progressive dysfunction and degeneration. We also explore one of the most challenging aspects of ALS: the combination of impaired glucose metabolism and hypermetabolism. Many patients burn calories at an accelerated rate while simultaneously struggling to generate adequate cellular energy, leading to rapid weight loss, muscle wasting, and faster disease progression despite seemingly adequate food intake. This is where ketones enter the conversation. We discuss how beta-hydroxybutyrate (BHB) and acetoacetate provide an alternative fuel source that can cross the blood-brain barrier and potentially bypass some of the metabolic bottlenecks associated with glucose utilization. Beyond energy production, BHB may also function as a signaling molecule that influences inflammation, oxidative stress, and cellular resilience—all areas of growing interest in neurodegenerative disease research. However, we also address an important clinical challenge: traditional ketogenic diets often suppress appetite and promote weight loss, which can be problematic for individuals with ALS. This has led researchers to investigate alternatives such as exogenous ketones and medium-chain triglycerides (MCTs) that may raise ketone levels without requiring severe caloric restriction. Finally, we discuss the importance of comprehensive monitoring, including albumin, ApoB, lipid panels, ketone levels, glucose markers, and hs-CRP, to help track metabolic status and nutritional health throughout any therapeutic intervention. While ketogenic metabolic therapy is not a cure for ALS and remains an evolving area of research, it represents an important shift in thinking—from focusing solely on damaged neurons to also supporting the cellular energy systems that keep them alive. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile [https://quicklabmobile.com] 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

Episode 111 | Crohn’s And The Gut Barrier

A diagnosis of severe Crohn’s disease often comes with a familiar message: manage the condition, suppress inflammation, and prepare for a lifetime of treatment. But what happens when a case report challenges that narrative? In this episode of The Health Pulse, we examine a fascinating 2016 case report involving a 14-year-old patient with active Crohn’s disease who experienced dramatic improvements after following a Paleolithic Ketogenic Diet (PKD). What makes this case particularly compelling is that the reported changes went beyond symptom relief. Researchers documented improvements in inflammatory markers, imaging findings, and measures of intestinal permeability, raising important questions about the relationship between diet, gut barrier function, and immune activity. We break down what separates PKD from a conventional ketogenic diet. This therapeutic approach focuses on animal fat, meat, organ meats, and eggs, while eliminating grains, legumes, dairy, processed foods, seed oils, and nearly all plant foods. We explore the competing theories behind its potential effects: Is the benefit driven by ketosis itself, the removal of common dietary triggers, improvements in gut permeability, or a combination of all three? A major focus of the conversation is the concept of intestinal permeability ("leaky gut") and its possible role in Crohn’s disease. We explain how tight junctions regulate the gut barrier, how permeability can be measured using tests such as the PEG 400 test, and why objective measurements are often more meaningful than symptom reports alone. Most importantly, we discuss the limitations of case reports. While a single case can generate powerful hypotheses, it cannot establish cause and effect or prove a treatment works for everyone. We also review the biomarkers that may help monitor disease activity and response to therapy, including CRP, ESR, nutrient status markers, and metabolic health indicators. Whether you're interested in Crohn’s disease, inflammatory bowel disease, therapeutic nutrition, or the science of gut health, this episode offers a balanced look at a controversial but thought-provoking area of research. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile [https://quicklabmobile.com] 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.